Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product:
Active Ingredients:

Dosage Form:
New Zealand Sponsor:
Manufacturers:

Priorix
Measles vaccine, Schwarz strain 1000CCID50
Mumps virus, live attenuated, RIT 4385 5012CCID50
Rubella virus, Wistar RA27/3 strain 1000CCID50
Powder for injection with diluent
GlaxoSmithKline (NZ) Limited
GlaxoSmithKline Biologicals SA, Rixensart, Belgium
Fidia Farmaceutici SpA Divisione Solmag, Padova, Italy
GlaxoSmithKline Biologicals Corixa Corporation, Pennsylvania, United States of America

Dated this 13th day of November 2014.

STEWART JESSAMINE, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

Tags

Notice Number

Issue Number